Found 6 matching trials
Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/Lymphoma PHASE1 The purpose of this study is to estimate the safety and the efficacy of CAR...
Show More Location
Belarussian Research Center for Pediatric Oncology, Hematology and Immunology
Learn More & Join Trial
CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL PHASE1 The purpose of this study is to evaluate the safety and efficiency of autol...
Show More Location
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Learn More & Join Trial
Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells PHASE1 The aim of this prospective study is to evaluate the feasibility and effica...
Show More Location
Biotherapeutic Department of Chinese PLA General Hospital
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma PHASE1 This study will evaluate the efficacy, safety, and pharmacokinetics of cevo...
Show More Status
Active Not Recruiting
Location
University of Colorado
Learn More & Join Trial
Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia PHASE1 This phase I trial studies the side effects and best dose of CD19/CD20 chim...
Show More Status
Active Not Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab) PHASE2 Despite the consequent use of Tocilizumab together with conventional antipy...
Show More Learn More & Join Trial